Analysis and Characterization of Biologic Implants
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01060046|
Recruitment Status : Completed
First Posted : February 1, 2010
Last Update Posted : May 14, 2018
|Condition or disease|
|Ventral Hernia Post-mastectomy Breast Reconstruction|
|Study Type :||Observational|
|Actual Enrollment :||241 participants|
|Official Title:||Analysis and Characterization of in Vivo Tissue Remodeling in Routine Biologic Mesh Explants From Patients Undergoing Reoperation for Recurrent Hernia or Revision of a Prior Surgical Site|
|Study Start Date :||August 2007|
|Actual Primary Completion Date :||January 2017|
|Actual Study Completion Date :||January 2017|
Patients with previously implanted biologic mesh
All patients undergoing a repeat operation to repair a recurrent hernia or to revise a surgical site which has been previously repaired using a biologic mesh.
Any patient undergoing a surgical procedure where fascial biopsy would not compromise the integrity of the procedure.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01060046
|United States, Missouri|
|Washington University School of Medicine|
|Saint Louis, Missouri, United States, 63110|
|Principal Investigator:||Brent D Matthews, MD||Washington University School of Medicine|
|Study Director:||Corey Deeken, PhD||Washington University School of Medicine|